New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 12, 2014
08:01 EDTBSTCBioSpecifics price target raised to $38 from $28 at MKM Partners
MKM Partners raised its price target for BioSpecifics shares to $38 citing higher Xiaflex royalty estimates following Auxilium's results. The firm reiterates a Buy rating on BioSpecifics.
News For BSTC From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 21, 2014
08:35 EDTBSTCBioSpecifics announces new data on XIAFLEX for Peyronie's Disease
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use